Position history for BlackRock Finance, Inc.'s holdings in IMMUNITYBIO INC
BlackRock Finance, Inc. holds 11.4M shares of IBRX (IMMUNITYBIO INC), worth $72.2M as of 2024-Q2. The position was increased (++10.1% shares). IBRX represents 0.0% of BlackRock Finance, Inc.'s portfolio.
Current Value
$72.2M
Current Shares
11.4M
Total Value Change
$0
Total Shares Change
0
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Upgrade to Pro to see multi-quarter position history and trends. View plans
Increased |
| 11.4M |
+10.1% |
| $72.2M |
| 0.0% |
| $6.32 |
33 |